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A B S T R A C T
Ethnopharmacological relevance: Despite advances in modern therapeutic strategies, cancer remains the second
leading cause of death worldwide. Therefore, there is a constant need to develop more efficient anticancer
targeting strategies. The anticancer therapeutic proprieties of medicinal plants and their bioactive compounds
have been reported for several years, making natural extracts and/or compounds derived from these a promising
source of novel anticancer agents. Sand dune plants are subjected to severe environmental stresses, leading to the
development of adaptations, including the production of secondary metabolites with a wide range of bioactiv-
ities, such as: anti-inflammatory, analgesic, antiseptic, hypoglycaemic, hypotensive, antinociceptive, antioxidant
and anticancer.
Aim of the study: The anticancer potential of sand dune plants remains under-investigated, so this research de-
scribes the characterisation of the composition of bioactive EOs from sand-dune plants of Peniche (Portugal), and
assessment of their activity in vitro and potential mechanism of action.
Materials and methods: EOs were extracted from six sand-dune species of plants from Peniche sand dunes: Crithmum
maritimum L., Seseli tortuosum L., Artemisia campestris subsp. maritima (DC.) Arcang., Juniperus phoenicea var. turbinata
(Guss.) Parl., Otanthus maritimus (L.) Hoffmanns. & Link, and Eryngium maritimum L.. EOs composition was fully
characterised chemically using Gas Chromatography-Mass Spectrometry (GC-MS). The assessment of anticancer
activity and mechanism of action was performed in vitro using breast and colorectal cancer 2D and 3D spheroid cell
line models, through cell proliferation assay, western blotting analysis, and cell cycle analysis.
Results: EOs from the majority of the species tested (S. tortuosum, A. campestris subsp. maritima, O. maritimus, and E.
maritimum) were mainly composed by hydrocarbon compounds (sequisterpenes and monoterpenes), showing anti-
proliferative activity in both 2D and 3D models. EO extracted from S. tortuosum and O. maritimus were identified as
having the lowest IC50 values for both cell lines when compared with the other species tested. Furthermore, this
antiproliferative activity was associated with increased p21 expression and induction of apoptosis.
Conclusions: The present study suggests that EOs extracted from S. tortuosum and O. maritimus present promising
cytotoxic properties. Further evaluation of the extracts and their key components as potential anticancer agents
should therefore be explored.
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1. Introduction
Cancer remains the second leading cause of death worldwide, re-
sponsible for 8.7 million deaths per year, even though improvements in
diagnosis and treatment strategies and an increased understanding of tu-
mour biology (Fitzmaurice et al., 2017; Nagai and Kim, 2017). Cancer de-
velopment and progression is driven by a series of genetic and epigenetic
alterations that lead to a dysregulated cell proliferation, survival, and in-
vasiveness, promoted by cell cycle progression deregulation, angiogenesis,
metabolic switch, and resistance to apoptosis (Roos et al., 2016; Sever and
Brugge, 2015). Conventional anticancer therapeutic strategies continue to
mostly rely on either radiotherapy or conventional chemotherapy ap-
proaches (Miller et al., 2016). Interestingly, several of these chemotherapy
compounds are either directly derived from plant extracts or chemically
modified versions of specific phytoproducts, including conventional che-
motherapy agent taxol/paclitaxel (Blowman et al., 2018). Plants and their
bioactive compounds have been used in the treatment of disease since an-
cient times. An increasingly expanding body of research has demonstrated
that plant-derived products have promising anti-inflammatory, anti-bac-
terial, anti-oxidant, and anticancer effects, with fewer side-effects than other
compounds (Blowman et al., 2018; Cabral et al., 2017; Dhifi et al., 2016).
EO (essential oil) phytoproducts comprise multifunctional chemical com-
pounds extracted from aromatic plants and are responsible for the great
majority of therapeutic activity attributed to these plants (Edris, 2007;
Sharifi-Rad et al., 2017). EOs are secondary metabolites, mainly constituted
by oxygenated compounds and hydrocarbons, in which the proportion and
concentration of the complex mixture will determine the biological activity
of the EO (Blowman et al., 2018; Gautam et al., 2014). Some of the main
chemical constituents of EOs are terpenes, which are associated with various
biological activities, including anticancer proprieties (Dhifi et al., 2016).
Vegetation patterns in coastal sand dunes hold particular interest for
ecologists, in part because of their clear interaction with the dune geo-
morphology (Cowles, 1911). Coastal sand dunes are subjected to severe
environmental stresses and disturbance, caused by salinity, drought,
nutrient limitation, substrate instability, sand burial, wind abrasion,
erosion of the coastline and storms (Gornish and Miller, 2010).
Sand-dune species, due to their understudied and unexplored stress
adaptation mechanisms and strategies present an opportunity for the
discovery of new bioactive molecules (Murray et al., 2013). However,
although work in this field has expanded in the last few years, the role
of EOs as potential anti-cancer agents is still not fully explored (Gautam
et al., 2014; Bhalla et al., 2013). The aromatic plants present in the sand
dunes of Peniche, chosen for this research are described below.
The genus Artemisia L. is widespread throughout the world, growing
wild over the Northern Hemisphere and belongs to the Asteraceae family.
Artemisia campestris subsp. maritima (DC.) Arcang. grows in Coastal sands,
usually in primary dunes (Djeridane et al., 2007). This species has been
used as febrifuge, vermifuge, against digestive troubles, gastric ulcer,
menstrual pain (Dob et al., 2005; Djeridane et al., 2007) and for medicinal
uses, such as antispasmodic and antihelmintic (Naili et al., 2010).
Crithmum maritimum L., commonly known as sea fennel or rock
samphire, is a perennial member of the Apiaceae family (Meot-Duros
et al., 2010). It has been attributed many interests in traditional med-
icine, including diuretic, antiscorbutic, digestive and purgative prop-
erties, and can be consumed as a condiment (Atia et al., 2006).
The genus Eryngium L. belongs to the family Apiaceae and includes
around 250 species that are widespread throughout the world (Darriet et al.,
2014). Among them, several Eryngium species have been used as ornamental
plants, condiments or in traditional medicine (Küpeli et al., 2006; Darriet
et al., 2014). Eryngium maritimum L., usually named ‘sea holly’ in England or
‘Panicaut desmers’ in France, grows wild on the sandy beaches of western
Europe, the Mediterranean basin and the Black Sea (Küpeli et al., 2006a;
Darriet et al., 2014). The plant is one of the typical dune species implicated
in the plant network that contributes to sand dune edification and re-
storation (Darriet et al., 2014). E. maritimum has also been reported to ex-
hibit different therapeutic uses in folk medicine (Küpeli et al., 2006a).
The genus Juniperus L. (Cupressaceae) has approximately 70 species in
the Northern Hemisphere (Nakanishi et al., 2004; Seca and Silva, 2005).
Juniperus phoenicea var. turbinata (Guss.) Parl. is a bush growing in rela-
tively dry conditions in stabilized dunes and coastal cliffs, but also on rocky
slopes thermophilic, limestone outcrops and embedded river valleys (Seca
and Silva, 2005). Plants of the genus Juniperus are used in different Eur-
opean cuisines as spice and flavouring alcoholic drinks, as well as in cos-
metics (Loizzo et al., 2008). These plants have an extensive history of use in
global folk medicine for various disorders, such as common colds, urinary
and kidney infections and dermatological disorders (Allen and Hatfield,
2004). Many biological activities have been reported for Juniperus sp. in-
cluding anti-inflammatory (Akkol et al., 2009; Lesjak et al., 2011), diuretic,
antiseptic (bacterial and fungal) (Cavaleiro et al., 2006; Ennajar et al.,
2009), anthelmintic (Kozan et al., 2006), hypoglycaemic (Ju et al., 2008),
hypotensive, abortifacient, antinociceptive (Akkol et al., 2009), antiviral
(Sassi et al., 2008), anticancer (Kusari et al., 2011), anti-oxidant (Lesjak
et al., 2011) and analgesic properties (Lesjak et al., 2011).
Otanthus maritimus (L.) Hoffmans. & Link belongs to the family
Asteraceae. This species has been employed in folk medicine in de-
coctions as tonics, dyspeptics and for the treatment of toothache,
asthmatic bronchitis, dysentery and inflammation of the urinary
bladder (Reutter, 1923; Tsoukatou et al., 2000). In 2013, Cabral and
collaborators evaluated the anti-inflammatory activity in vitro and
comproved this bioactivity of the essential oil (Cabral et al., 2013).
Seseli tortuosum L. belongs to the family Apiaceae, which is composed of
aromatic herbs and economically important species that are used as foods,
spices, condiments and ornamentals (Lawrence, 1995; Crowden et al., 1969;
Pimenov & Leonov 1993). Several Seseli species are reported in ancient lit-
erature for various healing effects, namely herbal remedy for human in-
flammation, swelling, rheumatism, pain and common cold. In Turkish folk
medicine, the fruit of Seseli tortuosum is used as emmenagogue and anti-
flatulent (Baytop, 1999). This EO have been investigated for its various bio-
logical properties including anti-inflammatory, antinociceptive (Küpeli et al.,
2006b; Tosun et al., 2006) and antifungal activities (Gonçalves et al., 2012).
Bearing in mind that inflammation is a well established key hallmark of
cancer and has a key role in promoting tumorigenesis (Hanahan and
Weinberg, 2011), and taking into account that these sand-dune plants from
Peniche: A. campestris subsp. maritima, C. maritimum, E. maritimum, J. phoe-
nicea var. turbinata, O. maritimus and S. tortuosum have anti-inflammatory
properties, this study aims to assess the anticancer properties of the essential
oils (EOs) of these plants. EO extracts from these six species were tested as
potential cytotoxic agents using 2D and 3D in vitro models of cancer, as well
as, in a non-cancer cell line to evaluate off-target risks. Mechanisms of action
of the EOs presenting the most pronounced cytotoxic effect were further
evaluated regarding the impact on key signalling pathways involved in cell
survival, cell cycle regulation, and cell death mechanisms.
2. Materials and Methods
2.1. Plant materials
Plant samples were collected from the sand dunes of Consolação beach,
Peniche, Portugal. The aerial parts of the six species were collected during
the flowering stage (July). The voucher specimens were identified by a
plant taxonomist (Célia Cabral) and deposited in the Herbarium of
Medicinal Plants, Faculty of Pharmacy, University of Coimbra, under the
numbers: J. Poças 02013 (A. campestris subsp. maritima), J. Poças 06013 (C.
maritimum), J. Poças 02013 (E. maritimum), J. Poças 05013 (J. phoenicea var.
turbinata), J. Poças 01013 (O. maritimus), and J. Poças 04013 (S. tortuosum).
2.2. Extraction of essential oils
EOs were isolated by hydrodistillation for 3 h using a Clevenger-
type apparatus, according to the procedure described in the European
Pharmacopoeia (Council of Europe, 1997). Extracts were stored in glass
vials at 4 °C in the dark.
E. Beeby, et al. Journal of Ethnopharmacology 258 (2020) 112803
2
2.3. Chemical characterisation of essential oils using Gas Chromatography-
Mass Spectrometry (GC-MS)
EOs were analysed by gas chromatography (GC) for quantification of
extract components, and GC coupled with mass spectrometry (GC-MS)
for identification of EOs components, as previously described (Falcão
et al., 2018). In brief, the GC-MS unit consisted on a PerkinElmer system
with a Clarus® 580 GC module and a Clarus® SQ 8 S MS module,
equipped with DB-5MS fused-silica column (30 m × 0.25 mm i.d., film
thickness 0.25 μm; J&W Scientific, Inc.). Oven temperature was pro-
grammed, 45–175 °C, at 3 °C/min, subsequently at 15 °C/min up to
300 °C, and then held isothermal for 10 min; injector and detector tem-
peratures, 280 °C. The transfer line temperature was 280 °C; ion source
temperature, 220 °C; carrier gas, helium, adjusted to a linear velocity of
30 cm/s; split ratio, 1:40; ionization energy, 70 eV; scan range, 40–300 u;
scan time, 1 s. The software Turbomass (software version 6.1.0, Perki-
nElmer, Shelton, CT, USA) for Windows was used for data acquisition.
The identity of the components was assigned by comparison of their
retention indices, relative to C7–C40 n-alkane indices and GC-MS spectra
from a commercial MS database. Compounds were quantified as area
percentages of total volatiles using the relative values directly obtained
from peak total ion current (TIC). Analyses were performed in triplicate.
2.4. Cell line culture and treatment
HEK293-T cell line (human embryonic kidney), RKO cell line (colorectal
cancer), and MCF7 cell line (breast cancer) were purchased from ATCC and
ECCAC, respectively. Cells were cultured in Dulbecco's Modified Eagle's
Medium (DMEM; Biowest) supplemented with 10% fetal bovine serum
(FBS; Gibco) and 1% sodium pyruvate (Biowest). Cells were maintained at
37 °C and 5% CO2, in a humidified incubator. All cell lines were routinely
tested as negative for mycoplasma. For the various experimental setups,
cells (2D or 3D models) were treated with a range of concentrations of EOs
or the cytotoxic agent Doxorubicin hydrochloride (Sigma Aldrich). DMSO
(Dimethyl sulfoxide) was used as a vehicle control when relevant.
2.5. Spheroid generation, treatment, and imaging
Spheroids were grown using MCF7 cells, seeded at a density of
2 × 104 cells per well in ultra-low adherence round-bottomed 96-well
plates (Corning). At least 12 spheroids were generated per condition.
After aggregation, spheroids were treated and media was replaced
every 2 days for a total duration of 14-day treatment. Spheroids were
imaged using the GelCount instrument (Oxford Optronix), and spheroid
size was determined using the ImageJ software (NIH), as previously
reported (Pires et al., 2012; Schneider et al., 2012).
2.6. Cell viability and growth inhibition evaluation
Cell viability was evaluated through 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, using
the CellTiter 96® Aqueous One solution Cell proliferation assay (Promega) as
per manufacturer's instructions. In brief, cells were seeded at a density
2 × 104 (HEK293-T), 1 × 104 (RKO), and 5 × 103 (MCF7) cells per well in a
96-well plate. After 24 h, cells were treated with either vehicle (DMSO) di-
luted in media, or a serial dilution of EOs in media or with the cytotoxic agent
Doxorubicin. EOs were initially diluted in DMSO in a 1:4 ratio (EO/DMSO).
This was further diluted in media in order to obtain a 1 μL/ml concentration,
and further diluted 1:10 in order to obtain a range of EO concentrations
(1 μL/ml - 10−5 μL/ml). 48 h post-treatment, media was removed and re-
placed with fresh culture medium containing MTS reagent solution. Cells
were further incubated at 37 °C and 5% CO2. After 4 h, the absorbance of the
plate was read at 490 nm in a microplate reader (Bioteck ELx800). Growth
inhibition was determined as the percentage of viable cells in relation to
untreated cells. IC50 (half maximal inhibitory concentration) values were
calculated using GraphPad Prism Software (GraphPad Software).
2.7. Fluorescence-activated cell sorting (FACS) cell cycle analysis
Cells (adherent and floating) were harvested, the cell pellet was
resuspended in 1X PBS, and the cell suspension fixed in 70% Ethanol in
1X PBS. Cells were washed in 1X PBS and incubated in 1X PBS with
10 μg/ml of propidium iodide (Sigma) and 100 μg/ml of RNAse
(Sigma). FACS analysis was performed previously reported (Pires et al.,
2010), using a FACS Calibur analyzer (BD Biosciences). Data were
analysed using the ModFIT software (Verity Software House).
2.8. Cell lysis and western blot analysis
Whole cell lysates were prepared as previously described (Poujade
et al., 2018). Briefly, cells were washed with PBS 1X and detached me-
chanically. Detached cells were also collected. Cell pellets were re-
suspended with UTB lysis buffer (9 M Urea, 75 mM Tris-HCl pH 7.5 and
0.15 M β-mercaptoethanol). Lysates were sonicated and clarified, and
protein concentration was determined using a NanoDrop spectro-
photometer (ND-1000 version 3.5.2). 50 μg were loaded in SDS-PAGE
gels and processed for western blotting. The antibodies used for Western
blot analysis were anti-p53 DO1 (Santa Cruz Biotechnology), anti-p21,
anti-PARP, anti-pAKT, anti-total AKT (Cell Signalling Technology). Anti
β-actin (Santa Cruz Biotechnology) was used as loading control. Further
antibody details are present in Supplementary Table 1. Membranes were
developed using the Fluorescent Imager ChemiDoc system and the Imager
Lab software (Biorad). Densitometric analysis of band intensity relative to
the β-actin loading control bands and the vehicle only control samples
was performed using ImageJ software (NIH) (Schneider et al., 2012).
2.9. Statistical analysis
All the experiments were performed using triplicates, being re-
presentative of at least three independent experiments (replication is
noted in Figure legends). Results are expressed as mean ± SD, unless
otherwise noted. Statistical significance was determined by Student's t-
test (one variable) or 2-way ANOVA with Tukey post hoc multiple
comparison test using GraphPad Prism (GraphPad Software).
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
3. Results
3.1. Essential oils composition
Yield and main compounds for each species are summarized in
Table 1. The extracted EOs had variable yields for the different species,
ranging between 0.08% (E. maritimum) and 0.66% (S. tortuosum). The
highest yields were obtained for S. tortuosum and A. campestris subsp.
maritima with values of 0.66% and 0.47%, respectively. Additionally,
the descriptive analysis of EOs composition showed that S. tortuosum
and J. turbinata EOs are mainly composed by monoterpenes (Tables S2C
and S2F; Figs. S1C and S1F). The same is verified for C. maritimum and
O. maritimus EOs, which are also composed by monoterpenes (Tables
S2B and S2E; Figs. S1B and S1E). Meanwhile, E. maritimum EO is mainly
constituted by sesquiterpenes, contrary to A. campestris subsp. maritima
EO which presents a composition based on a mixture of monoterpenes
and sesquiterpenes (Tables S2D and S2A; Figs. S1D and S1A).
3.2. Evaluation of the cytotoxic effect of EOs extracts from the six dune
plant species panel
The potential antitumor activity of the EO extracts from the six species
was initially evaluated using the MTS proliferation/viability assay. MCF7
(breast) and RKO (colorectal) cancer cells were treated for 72 h with a serial
dilution range of concentrations of extracted EOs, starting at 1 μL/ml. Cell
viability was determined in relation to control samples (cells treated with
DMSO). EOs extracted from O. maritimus, S. tortuosum, A. campestris subsp.
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maritima, and E. maritimum exhibited a pronounced antiproliferative/anti-
viability effect in both cell lines (Fig. 1A and B, Table 2), as compared with
the known chemotherapy agent Doxorubicin (IC50 of 0.08 μM, Figs. S2–S3).
Interestingly, EOs extracted from C. maritimum and J. turbinata did not ex-
hibit a significant cytotoxic effect in either cell lines, as relative proliferative
capacity did not drop below 70% of control. IC50 (inhibitory concentration
needed to reduce proliferation/viability by 50% compared to control) va-
lues for each EO extract were also determined (Table 2). S. tortuosum and O.
maritimus EOs presented the lowest IC50 concentration values for the RKO
cell line, 0.034 and 0.34 μl/mL respectively. The outcome was similar for
MCF7 cells, with EOs obtained from S. tortuosum, O. maritimus, and E.
maritimum having the lowest IC50 concentrations (0.0086, 0.21, and 0.15 μl/
mL, respectively). Additionally, all extracts had a reduced cytotoxic effect in
non-cancer cells HEK-293 T relatively to the observed in cancer cell lines,
indicating a potential therapeutic window between cancer and non-cancer
cell treatment with the EO extracts (Fig. S4). These data indicate that EOs
extracted from O. maritimus, S. tortuosum, A. campestris subsp. maritima, and
E. maritimum induced a robust antiproliferative/anti-viability activity in
cancer cell lines in vitro.
MCF7 (A) and RKO (B) cells were seeded at a density of 1 × 104 and
5 × 103 cells per well in a 96-well plate, respectively. Triplicate wells
were seeded per condition. Cells were treated with a range of EO con-
centrations (1:10 serial dilution 1 μL/ml - 10−5 μL/ml). Vehicle-only
controls were prepared by diluting DMSO in media at 1 μL/ml. Cells were
exposed to EO treatment for 72 h and an MTS assay was subsequently
performed. Scatter plots (A, B) represent cell viability expressed as per-
centage survival of control (n = 3 independent experiments). IC50 values
for both cell lines (n = 3 independent experiments) are noted in Table 2.
3.3. Impact of treatment with EOs from the six dune plant species panel on
in vitro 3D cancer models
As four species were identified as having potential anti-proliferative
activity using the MTS assay, it was important to determine the efficacy
of all EO extracts in tumour microenvironmental-relevant models. For
this, multicellular spheroid models, derived from cancer cell lines, are
well established as in vitro 3D models to be used to test the therapeutic
efficacy of novel agents (Zanoni et al., 2016). MCF7 spheroids were
treated with the different EO extracts for 15 days (with treatment re-
plenished every 2–3 days), during which spheroid size was determined
(Fig. 2). As it can be observed, a decrease in spheroid volume in relation
to the vehicle control (DMSO) was observed for all species, with the
exception of C. maritimum EO extracts (Fig. 2B). The impact on spheroid
volume varied between species, with the most pronounced effects ob-
served for O. maritimus, E. maritimum, S. tortuosum, and J. turbinata EOs,
with a reduction of spheroid volume of more than 50% by 14 days
(Fig. 2C–G). Furthermore, O. maritimus and E. maritimum EO extract
treatment led to a clear reduction in spheroid volume and integrity even
after 6 days of treatment (Fig. 2C, F, and G). These data show that O.
maritimus, E. maritimum, and S. tortuosum EO extracts also have an an-
tiproliferative/anti-viability effect in more complex 3D in vitro models.
MCF7 3D spheroids were established from 2.5 × 104 cells/well. 12
spheroids were established per condition. Spheroids were treated with ei-
ther vehicle-only control (1 μL/ml DMSO in media) or 1 μL/ml EO extracts
from the 6 dune plants in media. Treatment was maintained for 15 days,
with medial refreshed regularly. Spheroids were imaged every 3 days and
spheroid volume was determined. (A-F) Histograms representing the mean
spheroid volume (n = 3 independent experiments): (A) A. campestris subsp.
maritima, (B) C. maritimum, (C) E. maritimum, (D) J. phoenicia var. turbinata,
(E) O. maritimus, and (F) S. tortuosum. *p < 0.05; **p < 0.01; ***p< 0.001
(G) Representative images of treated spheroids at days 0, 6, and 15.
3.4. Evaluation of the mechanism of action of S. tortuosum and O.
maritimum EO extracts
S. tortuosum and O. maritimus EO products were selected as the best leads
for further evaluation from our initial six species plant panel. This was due to
the EO extracts from these two species having the highest extraction yields
and lowest IC50 values. In order to evaluate the mechanism of action of these
extracts, two approaches were undertaken. Firstly, the impact of treatment
with these extracts on cell cycle regulation was evaluated using flow cyto-
metry (Fig. 3 and Table 3). Secondly, the impact of EO treatment on survival,
cell cycle, and apoptosis signalling pathways were analysed using western
blotting (Fig. 4 and Fig. S5). For both these approaches, MCF7 cells were
treated with 1 μl/mL EOs from S. tortuosum and O. maritimus for 24 and 48 h.
Treatment with 2 μM Doxorubicin was used as a positive control, as this is a
well-established conventional chemotherapy agent. The results in Fig. 3 in-
dicate there was no clear trend in changes in cell cycle distribution after EO
extract treatment, albeit a significant decrease (***p < 0.005 and
*p < 0.05) in the percentage of cells in the G1 phase after treatment with S.
tortuosum (24 h) and O. maritimus (48 h) was observed. Interestingly, al-
though there are no observable alterations of p53 levels, p21 protein ex-
pression is significantly upregulated in EO-treated samples (Fig. 4A and Figs.
S5A–B). This contrasted with treatment with Doxorubicin, which, as ex-
pected, had a clear impact on cell cycle distribution, including a decrease of
cells in G1/S phases and increase in G2/M phase, p53 stabilization and in-
crease in p21 expression, denoting a clear G2/M cell cycle arrest (Figs. 3–4,
Table 3, and Fig. S5C). Importantly, an increase in the sub-G1 population
(which can be associated with decreased viability through apoptosis induc-
tion) for EO treated samples was also observed, particularly for O. maritimum
(Fig. 3 and Table 3). In order to clarify if this is occurring via increased
apoptosis, PARP cleavage, a marker of apoptosis downstream of caspase
activation, was evaluated for all conditions using western blotting (Fig. 4 and
Fig. S5). A significant decrease in total PARP (PARP) levels and a significant
increase in cleaved PARP (cPARP) levels was observed for all samples
(Fig. 4A–B, Figs. S5A–B). These data indicate that loss of viability is poten-
tially occurring via induction of apoptosis. Finally, as there was no clear
stabilization of p53 in EO-treated cells, the impact of EO extract treatment on
other survival signalling pathways was also evaluated (Fig. 4). For this, AKT
and phospho-AKT levels were analysed using western blotting, as AKT sig-
nalling is associated with both pro-survival and anti-apoptosis regulation
(Kalimuthu and Se-Kwon, 2013). It was observed that, although there were
no observable alterations in total AKT levels after treatment, there is a sig-
nificant decrease in total phospho-ATK levels (Fig. 4A).
In summary, these data indicate that treatment with EOs extracted
from both S. tortuosum and O. maritimus did not induce a significant cell
cycle arrest response, albeit leading to increased p21 levels. However, EO
extract treatment increased pro-apoptotic signalling, concomitant with
decrease in pro-survival AKT expression. This indicates that the anti-
proliferative/anti-viability effect observed after treatment with these ex-
tracts can be underpinned by an increase in apoptotic cell death via AKT.
MCF7 cells were treated for 24 and 48 h with either vehicle-only
Table 1
Main components of EO extracts.
Species Yield (%) Main compounds (above 10%)
Artemisia campestris subsp. maritima 0.47 β-pinene isomer 1, γ-Muurolene
Crithmum maritimum 0.36 γ-terpinene, thymol methyl ether isomer 2, o-Cymene isomer 1, β-Phellandrene isomer 1
Eryngium maritimum 0.08 7-Tetracyclo [6.2.1.0 (3.8)0 (3.9)]undecanol, 4,4,11,11-tetramethyl-, D-germacrene
Juniperus turbinata subsp. turbinata 0.29 α-pinene, β-phellandrene isomer 2
Otanthus maritimus 0.12 Chrysanthenone isomer 1, Verbenyl acetate
Seseli tortuosum 0.66 α-pinene, β-pinene isomer 1
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control (1 μL/ml DMSO in media), 1 μL/ml S. tortuosum, 1 μL/ml O.
maritimum EO extracts, or 2 μM Doxorubicin. Samples were analysed by
flow cytometry for DNA content. (A–C) Proportion of cells in the dif-
ferent cell cycle phases (G1, S, G2/M), as well as subG1 cell debris
content (SubG1) is presented as percentages of total cell population.
Stacked bar graphs represent means for n = 3 independent experi-
ments. Statistical significance of differences between means of vehicle
control vs EO for both species, per timepoint and cell cycle phase is
noted on Table 2. (D–F) Representative FACS analysis histograms from
n = 3 independent experiments of S. tortuosum (D), O. maritimus (E),
and Doxorubicin (F) treatments. Key: i) Vehicle control 24 h; ii) EO/
Doxorubicin 24 h; iii) Vehicle control 48 h; ii) EO/Doxorubicin 48 h.
MCF7 cells were treated with either vehicle-only control (1 μL/ml
Fig. 1. Cytotoxic effect of EOs extracts from the 6 dune plant species panel.
Table 2
Cytotoxic effect of EOs extracts from the 6 dune plant species panel: IC50 values
for both cell lines.
Species IC50 (μL/mL)
MCF7 RKO
Artemisia campestris subsp. maritima 0.32 0.35
Crithmum maritimum ND ND
Eryngium maritimum 0.15 0.47
Juniperus turbinate subsp. turbinata ND ND
Otanthus maritimus 0.21 0.34
Seseli tortuosum 0.0086 0.034
Fig. 2. Impact of treatment with EOs from the 6 dune plant species panel on in vitro 3D cancer models.
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Fig. 3. Impact of O. maritimus and S. tortuosum EO extract treatment on cell cycle progression.
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DMSO in media), 1 μL/ml S. tortuosum or O. maritimum EO extracts (A)
or vehicle control/2 μM Doxorubicin (B) for 24 and 48 h p53, p21,
phospho-AKT, total AKT, and PARP levels were analysed by Western
blotting. β-actin was used as loading control. Representative blots of
n = 3 independent experiments are shown.
4. Discussion
Since ancient times plants have been used in medicine to treat dif-
ferent pathologies. Consequently, this traditional use conducted to an
increasing interest in the study of plants bioactive compounds as po-
tential therapeutic agents (Asadi-Samani et al., 2016). Moreover, phy-
toproducts, such as EOs, containing active chemical compounds have
been one of the main target focus for the design of novel anticancer
therapies (Blowman et al., 2018; Dhifi et al., 2016; Gautam et al., 2014).
Based on that, this work aimed to assess the anticancer activity of EOs
extracted from six species of sand-dune plants, containing in their che-
mical composition several compounds that have known therapeutic ac-
tivity. The present study has shown that EOs from S. tortuosum, O.
maritimus, and E. maritimum induced a significant decrease in cell via-
bility and/or proliferation, both in 2D and 3D in vitro cancer models, and
presented the lowest IC50 values of the panel of species. This cytotoxic
effect exhibited a profile similar to that with the conventional che-
motherapy agent Doxorubicin. These results were somehow expected, as
these EOs mixtures have in their composition compounds with pre-
viously described anticancer effects and present relative low cytotoxicity
effect in non-cancer cells treated with the same concentrations of EOs.
All compounds identified in the EOs of the species studied are either
predominantly monoterpenes (C. maritimum; J. turbinata; O. maritimus; and
S. tortuosum), sesquiterpenes (E. maritimum), or a mix of both these hydro-
carbon compounds (A. campestris) (Table 1). Previous studies have reported
anticancer activity induced by sesquiterpenes and monoterpenes, via
apoptosis and promotion of antiproliferative effect in cancer cell lines
(Asadi-Samani et al., 2016; Bhalla et al., 2013). Furthermore, Sylvestre and
colleagues analysed the chemical composition of Myrica gale EOs collected
into two fractions during extraction (30 and 60 min) and its anticancer ef-
fect. The higher percentage of compounds detected were monoterpenes
(30 min fraction) and sesquiterpenes (60 min fraction), with the 60 min
fraction showing a higher anticancer activity associated with decreased cell
viability (Sylvestre et al., 2005). A study by Lone and colleagues showed
that EO extracted from the leaf of Senecio graciliflorus was able to induce a
strong therapeutic effect against human lung cancer cell lines, with this
activity attributed to the main components of the EO, α-pinene (a mono-
terpene also present in S. tortuosum in the present study) and ocimene
(Lone et al., 2014). In another study, Ramadan and coworkers showed that
Egyptian juniper oil, containing 26.19% of α-pinene, was associated with a
more pronounced anticancer effect against HepG2, MCF7, and A549 cancer
cell lines when compared with the commonly used chemotherapeutic drug,
Doxorubicin (Ramadan et al., 2015). E. maritimum EO was shown to be
composed predominantly by sesquiterpenes, including germacrene D. A
recent study investigating the activity of EOs from Magnolia grandiflora
flowers, containing in majority monoterpenes and sesquiterpenes, including
germacrene D (sesquiterpene present in E. maritimum EO) and β-pinene
(monoterpene present in A. campestris and S. tortuosum EOs) induced a
cytotoxic effect against various cancer cell lines (Morshedloo et al., 2017).
Furthermore, several studies have indicated that monoterpenes identified in
O. maritimus EOs, such as chrysanthenone, are also components of extracts
from other species reported to have anticancer activities, such as Pulicaria
incisa and Artemisia herba-alba (Shahat et al., 2017; Tilaoui et al., 2015).
All the described works support the potential anticancer activity attributed
to the main compounds observed in the extracted EOs. However, it was not
possible, at this stage, to evaluate whether specific compounds, or mixture
of components, are responsible for the observed antiproliferative effects.
S. tortuosum and O. maritimus were further investigated to elucidate if the
Table 3
Impact of O. maritimus and S. tortuosum EO extract treatment on cell cycle progression. Statistical significance of differences between means of vehicle control
vs EO for both species, per timepoint and cell cycle phase.
subG1 G1 S G2/M
Vehicle only vs Seseli tortuosum 24 h p > 0.05 *p< 0.05 p>0.05 p > 0.05
Vehicle only vs Seseli tortuosum 48 h p > 0.05 p > 0.05 p > 0.05 p > 0.05
Vehicle only vs Othantus maritimus 24 h p > 0.05 p > 0.05 p > 0.05 p > 0.05
Vehicle only vs Othantus maritimus 48 h **p< 0.01 *p< 0.05 p>0.05 p > 0.05
Vehicle only vs Doxorubicin 24 h *p< 0.05 ****p< 0.0001 **p< 0.01 p>0.05
Vehicle only vs Doxorubicin 48 h ****p< 0.0001 ****p< 0.0001 *p< 0.05 ****p< 0.0001
Fig. 4. Impact of O. maritimus and S. tortuosum treatment on cell survival and cell death signalling.
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effect was cytostatic (solely impact on cell proliferation) or cytotoxic (in-
creased cell death). EOs from another species, E. maritimum, had a similar
impact on cell proliferation relative to the other two species, although the EO
extraction had a much lower yield, so was not further investigated. Our data
showed that the effect of the treatment with O. maritimum and S. tortuosum
were mostly associated with a cytotoxic effect underpinned by decreased
survival signalling and increased apoptosis. Previous studies support these
results, once they reported that the monoterpene components α-pinene, β-
pinene, and chrysanthenone have cytotoxic effect in cancer cells through pro-
apoptotic proprieties and the impact in the regulation of AKT pathway
(Suhail et al., 2011; Zhou et al., 2007). No significant impact on cell cycle
progression was observed for both O. maritimum and S. tortuosum EOs, even
though there was an increase of p21 levels, which presented a slight dis-
crepancy with the literature, as α- and β-pinene, some of the main com-
pounds of S. tortuosum EO, are known to be involved in cell cycle arrest
(Suhail et al., 2011). Thus, the results showed that O. maritimum and S. tor-
tuosum EOs most probably predominantly induced loss of viability via in-
duction of apoptosis. This antitumoral mechanism of action differs from the
positive control Doxorubicin, which induces apoptosis subsequent to DNA-
damage induced double-strand breaks and cell cycle arrest (Tacar et al.,
2013). EOs from other species previously reported to possess anticancer
properties to induce loss of viability and/or antiproliferative mechanisms
through a series of mechanisms, including direct impact on mitochondrial
potential activating the intrinsic apoptotic pathway, ER-stress signalling ac-
tivation, inhibition of survival pathways such as mTOR or NF??B signalling,
or increased oxidative stress (Girola et al., 2015; Hassan et al., 2010; Seal
et al., 2012). Therefore, future work will focus on further exploring the me-
chanism of action of S. tortuosum and O. maritimus regarding their cytotoxic
and pro-apoptotic activity. Of particular interest are the components of O.
maritimus, none of which have been reported in the literature to have an-
ticancer effects. Future work will also focus on evaluating the role of specific
components of EOs vs. the original complex extract mixtures, and any po-
tential impact of these in combination with more conventional therapeutic
approaches, such as conventional chemotherapy and radiotherapy, both in
vitro and in vivo.
To our knowledge, this is the first study proposing this class of
phytoproducts, i.e. EOs, from S. tortuosum and O. maritimus, as potential
and promising agents against cancer cells in vitro. These two EO mix-
tures show a pronounced cytotoxic effect against cancer cells, through
decreased survival signalling and induction of apoptosis.
5. Conclusion
Our study is the first to propose EO phytoproducts from S. tortuosum
and O. maritimus as potential and promising anti-cancer agents. These
two EOs show a cytotoxic effect against cancer cells, through decreased
survival signalling and induction of apoptosis.
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